IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism.
IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism.
复制标题
DOI:
10.1158/0008-5472.can-14-0772-t
复制
发表时间:
2014-06-15
期刊:
影响因子:
11.2
通讯作者:
Metallo CM
中科院分区:
文献类型:
--
作者:
Grassian AR;Parker SJ;Davidson SM;Divakaruni AS;Green CR;Zhang X;Slocum KL;Pu M;Lin F;Vickers C;Joud-Caldwell C;Chung F;Yin H;Handly ED;Straub C;Growney JD;Vander Heiden MG;Murphy AN;Pagliarini R;Metallo CM
Oncogenic mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) occur in several types of cancer, but the metabolic consequences of these genetic changes are not fully understood. In this study, we performed 13C metabolic flux analysis on a panel of isogenic cell lines containing heterozygous IDH1/2 mutations. We observed that under hypoxic conditions, IDH1-mutant cells exhibited increased oxidative tricarboxylic acid metabolism along with decreased reductive glutamine metabolism, but not IDH2-mutant cells. However, selective inhibition of mutant IDH1 enzyme function could not reverse the defect in reductive carboxylation activity. Furthermore, this metabolic reprogramming increased the sensitivity of IDH1-mutant cells to hypoxia or electron transport chain inhibition in vitro. Lastly, IDH1-mutant cells also grew poorly as subcutaneous xenografts within a hypoxic in vivo microenvironment. Together, our results suggest therapeutic opportunities to exploit the metabolic vulnerabilities specific to IDH1 mutation.